Pubblicazioni

Definitive weekly hypofractionated radiotherapy in cutaneous squamous cell carcinoma: response rates and outcomes in elderly patients unfit for surgery

2022 - INTERNATIONAL JOURNAL OF DERMATOLOGY

De Felice, Francesca; Musio, Daniela; De Falco, Dario; Grapulin, Lavinia; Magnante, Anna Lisa; Caiazzo, Rossella; Bulzonetti, Nadia; Tombolini, Vincenzo

Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region

2021 - LA RADIOLOGIA MEDICA

De Felice, F.; Musio, D.; Tombolini, V.

Stereotactic and hypofractionated radiotherapy associated with immune checkpoint inhibitor drugs: Analysis of local control, toxicity, and outcome in a single research centre case study

2021 - ANTICANCER RESEARCH

Anzellini, D.; de Sanctis, V.; Valeriani, M.; Reverberi, C.; Marinelli, L.; Massaro, M.; Vullo, G.; Facondo, G.; Sigillo, R. C.; Tosi, E.; Osti, M. F.

Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis

2019 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Ferella, L.; Limoncin, E.; Vittorini, F.; Chalaszczyk, A.; Sorce, C.; Grimaldi, G.; Franzese, P.; Ruggieri, V.; Varrassi, E.; Di Staso, M.; Gimenez De Lorenzo, R.; Marampon, F.; Tombolini, V.; Masciocchi, C.; Gravina, G. L.

Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3Â Gy/fraction)

2019 - LA RADIOLOGIA MEDICA

Valeriani, M.; Marinelli, L.; Nicosia, L.; Reverberi, C.; De Sanctis, V.; Mollo, D.; Osti, M. F.

Inoperable early-stage primary and early recurrent non-small cell lung cancer: outcomes of a mono-institutional experience using a moderate hypofractionated schedule

2019 - LA RADIOLOGIA MEDICA

Valeriani, M.; Marinelli, L.; Reverberi, C.; De Sanctis, V.; Mollo, D.; Nicosia, L.; Osti, M. F.